Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.61ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.61NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.153ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.153ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.153ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.153NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.62ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.62NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.391ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.391ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.391ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.391NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.448ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.448ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.448ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.448NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Q.1 (Alpha)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Q.1 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.1 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.1 (Alpha)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.46 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.46 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.46 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.46 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.99 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.99 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used